Podcast Episodes
Back to SearchExploring the possibility of early interception in smoldering myeloma: novel agents, challenges & advances in risk stratification
Episode 241
Smoldering multiple myeloma (SMM) and monoclonal gammopathy of undetermined significance (MGUS) are two well-known precursor conditions to multiple m…
2 years, 6 months ago
CHIP & CCUS: knowledge gaps, ongoing trials & recommendations for approaching patients with myeloid precursors
Clonal hematopoiesis of indeterminate potential (CHIP) and clonal cytopenia of unknown significance (CCUS) are considered precursor diseases to hemat…
2 years, 6 months ago
CHIP & CCUS: knowledge gaps, ongoing trials & recommendations for approaching patients with myeloid precursors
Episode 240
Clonal hematopoiesis of indeterminate potential (CHIP) and clonal cytopenia of unknown significance (CCUS) are considered precursor diseases to hemat…
2 years, 6 months ago
Monoclonal B-cell lymphocytosis: classification, biology and exploring the possibility of early interception
Monoclonal B-cell lymphocytosis (MBL) is a condition characterized by the presence of an abnormal increase in B lymphocytes in the blood. MBL is cons…
2 years, 6 months ago
Monoclonal B-cell lymphocytosis: classification, biology and exploring the possibility of early interception
Episode 239
Monoclonal B-cell lymphocytosis (MBL) is a condition characterized by the presence of an abnormal increase in B lymphocytes in the blood. MBL is cons…
2 years, 6 months ago
The impact of CAR-T therapy on the myeloma treatment landscape, patient selection for CAR-T & the evolving role of autoSCT
The introduction of CAR-T therapy has revolutionized the myeloma treatment landscape, offering a promising therapeutic approach for patients with rel…
2 years, 6 months ago
The impact of CAR-T therapy on the myeloma treatment landscape, patient selection for CAR-T & the evolving role of autoSCT
Episode 238
The introduction of CAR-T therapy has revolutionized the myeloma treatment landscape, offering a promising therapeutic approach for patients with rel…
2 years, 6 months ago
Diagnosing amyloidosis, currently available therapies & the importance of cardio-oncology
While there have been advances in the treatment and management of amyloidosis in recent years, diagnosis remains a challenge due to the highly varied…
2 years, 6 months ago
Diagnosing amyloidosis, currently available therapies & the importance of cardio-oncology
Episode 237
While there have been advances in the treatment and management of amyloidosis in recent years, diagnosis remains a challenge due to the highly varied…
2 years, 6 months ago
Addressing the importance of lymphodepletion, factors contributing to ICAHT & the cost effectiveness of CAR-T therapy
Although CAR-T cells have revolutionized the treatment of hematological malignancies, there are several important factors that must be addressed rega…
2 years, 7 months ago